The Journal of Experimental Medicine publishes immunology, cancer, stem cells, microbial pathogenesis, vascular biology, neurobiology. Est. 1896 - @RockUPress
Yang Yu, Yanling Zhao, Zhongcheng Shi, Larry L. Wang et al. demonstrate that CAMKV, previously classified as a nonfunctional pseudokinase, possesses intrinsic kinase activity driven by MYC/MYCN oncogenes to promote #neuroblastoma growth. hubs.la/Q04ykZ360
Insights: Sajiki, Araki et al. (hubs.la/Q04ykYf40) show that long-lived naive #CD8#Tcells accrue tonic #TCR signaling during homeostasis, driving their differentiation into functionally superior effectors. From Hee Yeun Won & Jung-Hyun Park: hubs.la/Q04ykYhq0
✍️💻 Participate in a complimentary Journal-Based #CME activity that consists of a full-text article that is free to read, a multiple-choice question test, and an evaluation/self-assessment. Our latest CME Activity @MSKCME is NOW available 👉 hubs.la/Q04wgC0S0
📢 We're now accepting applications for the JEM Early Career Travel Award, for grad students & early-career postdocs to participate in #VIB#Neuroimmunology Conference @VIBTrainConf in Antwerp!
Deadline ⏰ October 16, 2026
Apply here 👉 hubs.la/Q04xTnCC0
Florez-Paz & Mentis demonstrate the presence of supernumerary synapses during development, resulting in miswired immature spinal circuits. Two molecularly distinct mechanisms are responsible for their refinement, incl. a surprising CD47-dependent mechanism hubs.ly/Q04xFWyB0
Zhang et al. identify RalA-dependent signaling as a regulator of age-related #skeletalmuscle dysfunction. The novel compound UA-30 inhibits RalA activity, reduces muscle #fibrosis, improves mitochondrial function & mobility, & extends survival in mice. hubs.ly/Q04xFVZX0
“JEM doubtlessly is among the most prestigious journals in the overall field of medicine and in particular for the fields of immunology and inflammation.” — Ignacio Melero @ClinicaNavarra
Learn more about submitting to a journal valued by the community: hubs.la/Q04xy3xQ0
Read Dr. Melero and colleagues’ JEM study TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. rupress.org/jem/article/223/…
New content is available in our journal-based #CME activities @MSKCME: 📄 “Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccine” (Conde et al. hubs.la/Q04wfwBF0)
Begin the activity 👉 hubs.la/Q04wfFYR0
Explore our #cancer#Immunotherapy collection showcasing a broad range of topics, including the therapeutic potential of targeting cDC1, a strategy to harness the immunosuppressive potential of inhibitory receptors, and more: 👉 hubs.la/Q04v-Jnf0
Michalets et al. demonstrate that upper respiratory tract tissue-resident memory #CD8⁺ T cells are sufficient to protect against respiratory virus transmission, even in the absence of #CD4#Tcells, #Bcells, or lower respiratory tract immune responses. hubs.la/Q04x7-HH0
🔬NEW RESEARCH -How do our #cells maintain rapid bursts of #inflammation to fight #pathogens? 🔥 In this new #collaborative#paper with Prof Xiaopeng Qi @JExpMed, we show that the inflammatory signalling control centre within the cell, called the inflammasome, must be fueled. 1/3
ALT Vps4B controls caspase-1 dynamics at the ASC speck to drive inflammasome activation
Li et al. identify that the ATPase Vps4B controls caspase-1 dynamics at the ASC speck to promote #inflammasome activation. This self-rejuvenating mechanism of the ASC speck opens up new avenues for therapeutic intervention in inflammatory diseases. hubs.la/Q04x2Pfh0
JEM is pleased to present opportunities to engage in #CME@MSKCME. The latest activity is now available 👉 hubs.la/Q04wfD_20
📄 New content: “Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccine” (hubs.la/Q04wfz6H0)